Immunolocallzat1on of inducible and constitutive nitric oxide synthases in human bladder cancer

Urology

Volumn 54, Issue 3, 1999, Pages 416-419

  Klotz, Theo ^a   Bloch, Wilhelm ^a   Jacobs, Georg ^a   Niggemann, Sandra ^a   Engelmann, Udo ^a   Addicks, Klaus ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; ISOENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

AGED; ANGIOGENESIS; ARTICLE; BIOSYNTHESIS; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CLINICAL ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSURETHRAL RESECTION; TUMOR BIOPSY; BLADDER TUMOR; CHEMISTRY; ENZYMOLOGY; IMMUNOLOGY; MALE; METABOLISM;

AGED; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; NADP; NITRIC OXIDE SYNTHASE; URINARY BLADDER NEOPLASMS;

EID: 0032586931     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00212-5     Document Type: Article

References (14)

1. Moncada S, and Higgs A: The L-arginine nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
2. Lejeune P, Lagadec P, Onier N, et al: Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152: 5077-5083, 1994.
3. Jenkins DC, Charles IG, Thomson LL, et al: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci 92: 4392-4396, 1995.
4. Persson K, Igawa Y, Mattiason A, et al: Inhibition of the arginine/nitric oxide pathway causes bladder hyperactivity in the rat. Acta Physiol Scand 144: 107-108, 1991.
5. Thomsen LL, Lawton FG, Knowles RG, et al: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354, 1994.
6. Klotz T, Bloch W, Volberg C, et al: Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 82: 1897-1903, 1998.
7. Jansson OT, Morcos E, Brundin L, et al: Nitric oxide synthase activity in human renal cell carcinoma. J Urol 160: 556-560, 1998.
8. Swana HS, Smith SD, Perrota PL, et al: Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. J Urol 161: 630-634, 1999.
9. Andrade SP, Hart ID, and Piper PJ: Inhibitors of nitric oxide synthase selectively reduce flow in tumor associated neovasculature. Br J Pharmacol 107: 1092-1095, 1992.
10. Edwards P, Cendan JC, Topping DB, et al: Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 63: 49-54, 1996.
11. Ziche M, Morbidelli L, Masini E, et al: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94: 2036-2044, 1994.
12. Ziche M, Morbidelli L, Choudhuri R, et al: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997.
13. Gallo O, Masini E, Morbidelli L, et al: Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90: 587-596, 1998.
14. Campbell S, Volpert OV, Ivanovich M, et al: Molecular mediators of angiogenesis in bladder cancer. Cancer Res 58: 1298-1304, 1998.